Detalles de la búsqueda
1.
Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-Up of Prognostic Study Using Propensity Score Matching.
Oncology
; 100(5): 257-266, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114682
2.
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.
Ann Surg Oncol
; 26(7): 2175-2183, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941655
3.
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.
BMC Cancer
; 18(1): 982, 2018 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30326862
4.
High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
J Surg Oncol
; 118(1): 228-237, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29936704
5.
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
World J Surg Oncol
; 16(1): 26, 2018 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29433529
6.
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.
Int J Clin Oncol
; 21(2): 254-261, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26338270
7.
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.
Breast Cancer Res Treat
; 154(3): 521-31, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26573829
8.
Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers.
Int J Clin Oncol
; 19(3): 467-72, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23821234
9.
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.
J Med Case Rep
; 18(1): 214, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38689362
10.
A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1.
Gan To Kagaku Ryoho
; 37(7): 1397-400, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20647736
11.
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes.
Anticancer Res
; 40(5): 2871-2880, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32366437
12.
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin.
Anticancer Res
; 40(7): 4147-4156, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620664
13.
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.
Oncotarget
; 11(1): 86-98, 2020 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002126
14.
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.
Mol Clin Oncol
; 10(2): 275-284, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680208
15.
A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.
Anticancer Res
; 39(10): 5653-5662, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570463
16.
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine.
Sci Rep
; 9(1): 1811, 2019 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30755651
17.
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
Breast Cancer
; 26(6): 738-747, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31098866
18.
Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.
Int J Oncol
; 52(5): 1539-1558, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29512727
19.
Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
Clin Breast Cancer
; 18(5): 400-409, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29605174
20.
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.
Breast Cancer
; 24(2): 245-253, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27040403